Sign in

CIK 0001579428 · Large accelerated filer

Axsome Therapeutics, Inc.

Sign in to watch
Ticker
AXSM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
454241907
Phone
(212) 332-3241
Business address
ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Planned sale Director sold 25,000 shares at $161.11 ($4,027,750)
  9. 4 Planned sale Chief Operating Officer sold 35,378 shares at $161.88 ($5,726,991)
  10. 4 Option exercise Director acquired 6,250 shares (option exercise)
  11. 4 Option exercise Director acquired 12,485 shares (option exercise)
  12. 4 Option exercise Director acquired 5,193 shares (option exercise)
  13. 4 Planned sale Chief Executive Officer sold 32,410 shares at $185.60 ($6,015,296)
  14. 4 Planned sale Chief Financial Officer sold 12,000 shares at $187.92 ($2,255,040)
  15. 4 Planned sale Chief Commercial Officer sold 7,500 shares at $184.44 ($1,383,300)
  16. 4 Planned sale Chief Executive Officer sold 139,414 shares at an average $171.30 ($23,881,618)
  17. 4 Planned sale Director sold 37,577 shares at $165.18 ($6,206,969)
  18. 4 Planned sale Chief Executive Officer sold 79,973 shares at an average $145.66 ($11,648,582)
  19. 4 Planned sale Chief Executive Officer sold 163,939 shares at an average $133.07 ($21,815,669)
  20. 4 Planned sale Chief Executive Officer sold 45,384 shares at an average $119.38 ($5,418,060)

Page 2 of 11 · 211 filings